1 in 4 US Adults With Diabetes Used Injectable GLP-1 Drugs Last Year
Between 2016 and 2022, the rate of US adults with type 2 diabetes who used glucagon-like peptide-1 (GLP-1) receptor agonists rose from about 4% to nearly 20%, according to the Medical Expenditure Panel Survey Household Component. Now, new data from the Centers for Disease Control and Prevention reveal that almost 27% of adults diagnosed with […]
“Weight loss drugs present design challenges and opportunities”
The rise of appetite‑suppressing drugs such as Ozempic and Wegovy isn’t just shrinking their tens of millions of users worldwide, it’s reshaping consumption habits. That, in turn, is forcing food and beverage brands to rethink and redesign their output. When people suddenly want less food but better nutrition, it forces companies to reconsider everything from […]
Molecular Afterglow of Lophine‐Based Luminophore and Its Imaging Applications
We discovered that lophine—the first historically documented chemiluminescent compound—can be converted from weak chemiluminescence to bright molecular afterglow by caging its imidazole moiety. This switch greatly enhances its emission intensity, enabling, for the first time, the use of lophine derivatives for in vivo imaging applications, including reactive oxygen species (ROS) detection and monitoring adipose tissue […]
Marriage and Sex in the Age of Ozempic
In the last few years, GLP-1 weight-loss drugs like Ozempic and Zepbound have been radically reshaping the people’s lives, changing appetites and health. But the drugs also have the power to affect other parts of consumers’ lives, including their romantic relationships. Lisa Miller, who writes about health for The New York Times, tells the story […]
Novo Nordisk: Oral Wegovy Nears FDA Decision As GLP-1 Momentum Builds
How to avoid the dreaded fat jab REGAIN in 8 steps… from the £1 spice to ‘nature’s Ozempic’ snacks and nifty trick
THEY’VE been hailed a ‘silver bullet’, making the skinny dreams of millions come true. But once the wish of a trim figure is granted, what’s next for the fat jab fanatics – and just how can they keep the weight off when the food noise returns? Dr Clare and son Dr Jack reveal what Michael […]
Novo Nordisk: Oral Wegovy Nears FDA Decision As GLP-1 Momentum Builds
Post Content
Dangerous ‘gray-market’ weight-loss drugs flooding US as experts warn of risks
As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray-market” GLP-1s (such as semaglutide or tirzepatide) are not evaluated […]
Q&A: Oaktree picks its spot in AI boom
PitchBook Newsletters Bain bags $14B for 14th flagship PE fund; EA’s $55B LBO marks reset for gaming; Paramount lands Andreessen-backed news outlet; fresh foodtech data Read online | Don’t want to receive these emails? Manage your subscription. Log in The Daily Pitch: Europe October 7, 2025 Presented by Enterprise Ireland 💰 Bain Capital raised $14 […]
Doctors Reveal The Most Common Side Effects Of GLP-1s — And How To Manage Them
Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.